Click a link below to view the mailing archive as if it had been sent to you.
| 2015-05-31 12:15 | | Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients and more... |
| 2015-05-31 00:15 | | ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival and more... |
| 2015-05-30 12:15 | | J&J multiple myeloma drug offers hope after others stop working -study and more... |
| 2015-05-30 00:15 | | Bristol-Myers Slumps as Cancer Drug Trial Results Disappoint and more... |
| 2015-05-29 12:15 | | Amgen preps an FDA pitch for its late-stage kidney drug and more... |
| 2015-05-29 00:15 | | U.S. court grants exclusivity for Amarin's Vascepa and more... |
| 2015-05-28 12:15 | | China jacks up registration fees for medical devices, drugs and more... |
| 2015-05-28 00:15 | | FDA approves Actavis, Valeant drugs for irritable bowel syndrome and more... |
| 2015-05-27 12:15 | | Post-swap Novartis preps cancer drug R&D road show and more... |
| 2015-05-27 00:15 | | The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war and more... |
| 2015-05-26 12:15 | | Consumers Sue Anthem for Denying Coverage for a Gilead Hepatitis C Drug and more... |
| 2015-05-26 00:15 | | Upcoming Events: A Dosing Decision For BioMarin, Plus Roche To Get Alzheimer's Data and more... |
| 2015-05-23 12:15 | | The Most Loved Biotechs of Big Hedge Funds and more... |
| 2015-05-23 00:15 | | Amgen ends collaboration with AstraZeneca on inflammation drug and more... |
| 2015-05-22 12:15 | | Abbott Laboratories: The Future Is As Bright As The Past and more... |
| 2015-05-22 00:15 | | Otonomy Inc's ear drug fails mid-stage trial and more... |
| 2015-05-21 12:15 | | Smith & Nephew gets in on OrthoSpace round and more... |
| 2015-05-21 00:15 | | Pfizer Would Benefit From Glaxo Takeover, Deutsche Bank Says and more... |
| 2015-05-20 12:15 | | Arena: Belviq Sales Flattening Out - Is It Sector Saturation? and more... |
| 2015-05-20 00:15 | | Achillion partners with J&J to develop hep C drugs and more... |
| 2015-05-19 12:15 | | Valeant Pharmaceuticals - A Global Acquirer That Could Be The Next Berkshire Hathaway and more... |
| 2015-05-19 00:15 | | The FierceBiotech panel: Top research execs tackle the fast-changing field of cancer drug R&D and more... |
| 2015-05-18 12:15 | | Hospira approval puts Pfizer on track to close $17bn deal by year's end and more... |
| 2015-05-18 00:15 | | What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug and more... |
| 2015-05-17 00:15 | | AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. and more... |
| 2015-05-15 12:15 | | 10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15 and more... |
| 2015-05-15 00:15 | | Pfizer gets friendly backing in appeal over blind rep's bid for paid driver and more... |
| 2015-05-14 12:15 | | Sanofi moving forward on Celiac disease immunotherapy development and more... |
| 2015-05-14 00:15 | | The 25 most influential people in biopharma in 2015 and more... |
| 2015-05-13 12:15 | | Senator asks VA to yank patent on Gilead's Sovaldi to crush its price and more... |
| 2015-05-13 00:15 | | Chugai Pharma Appears To Own U.S., Japan And EU Patent Rights To Medivation's Xtandi and more... |
| 2015-05-12 12:15 | | Pfizer continues its deal spree with a $600M option pact to buy AM-Pharma and more... |
| 2015-05-11 12:15 | | Is there a place for pharma in the emerging EHR market? and more... |
| 2015-05-11 00:15 | | These biotech names are ripe for mergers: Analysts |
| 2015-05-10 12:15 | | Legal Trouble May Be Coming For Osiris' Sales Executives and more... |
| 2015-05-10 00:15 | | Why Teva’s Specialty Medicines Performance Declined in 1Q15 and more... |
| 2015-05-09 12:15 | | Orexigen Therapeutics reports first-quarter loss but tops expectations and more... |
| 2015-05-09 00:15 | | California Court Deals Pharma a Setback in the Pay-to-Delay Debate and more... |
| 2015-05-08 12:15 | | Bellicum buys into CAR-T manufacturing amid a hot immuno-oncology race and more... |
| 2015-05-08 00:15 | | Keryx CEO 'pleased' with drug launch as firm expands in Boston and more... |
| 2015-05-07 12:15 | | An update on Tekmira: From Ebola promise to a strong hep B focus and more... |
| 2015-05-07 00:15 | | Under pressure, FDA to hold public meeting on off-label use and more... |
| 2015-05-06 12:15 | | Gilead's John C. Martin: One Breakthrough Drug After Another and more... |
| 2015-05-06 00:15 | | Vivus reports 1st-quarter loss but tops expectations and more... |
| 2015-05-05 12:15 | | Roche presses pause on PTC's SMA drug over a safety scare and more... |
| 2015-05-05 00:15 | | Back to first principles: a new model for the regulation of drug promotion and more... |
| 2015-05-04 12:15 | | The Most Widely Prescribed Medicare Part D Drug Was… Generic Vicodin and more... |
| 2015-05-03 12:15 | | Why Medicare's List Of Costly Drugs Is Kind Of Bogus and more... |
| 2015-05-03 00:15 | | Are Drug Mergers In Their Final Act? and more... |
| 2015-05-02 00:15 | | Celgene: Just How Worrisome is Its European Patent Hearing? and more... |
| 2015-05-01 12:15 | | Pfizer emerges as mystery bidder for rare disease firm Swedish Orphan and more... |
| 2015-05-01 00:15 | | Smith & Nephew 'working hard' on acquisitions trail, CEO says and more... |
